IDH1 and astrocytoma (excluding glioblastoma): In conclusion, a combination of early treatment and maximal use of awake craniotomies results in less serious postoperative deficits and lower epileptic burden in grade 2 astrocytomas, IDH mutant and oligodendrogliomas, IDH mutant and 1p19q codeleted as compared with a delayed, more conservative treatment strategy.